GLUE Monte Rosa Therapeutics, Inc. - Common Stock
$18.42
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$4–$26
66% of range
Analyst Rating
BUY
15 analysts
Price Target
$32
+76% upside
P/E (TTM)
—
ROE
-15.4%
Net Profit Margin
-31.2%
GLUE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$18.42
Market Cap
$1.03B
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$124M
Div Yield
0.00%
ROE
-15.4%
Debt/Equity
—
52W Range
$4 – $26
GLUE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$124M
2023-12-31
→
2025-12-31
EPS
—
Free Cash Flow
$-27M
2021-12-31
→
2025-12-31
Margins
-31.2%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
GLUE
Peer Median
P/S (TTM)
8.3
45.5
P/B
4.4
4.8
Price / FCF
-37.4
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
GLUE
Peer Median
Operating Margin
-43.8%
—
Net Profit Margin
-31.2%
-237.1%
ROA
-8.7%
-41.6%
ROE
-15.4%
-55.3%
ROIC
-22.6%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
GLUE
Peer Median
Current Ratio
6.1
5.7
Quick Ratio
2.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
GLUE
Peer Median
Revenue YoY
63.5%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
GLUE
Peer Median
Payout Ratio
0.00%
—
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
0.00%
Payout Ratio
0.00%
5Y Div CAGR
—
GLUE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 5 33.3%
- Buy 9 60.0%
- Hold 1 6.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-05-14
Median
$30.50
Mean
$32.33
← Below all targets
$18.42
Low
$29.00
High
$37.00
Median target
$30.50
+65.6%
Mean target
$32.33
+75.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.20%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.45 | $-0.39 | -0.06% |
| Dec. 31, 2025 | $-0.56 | $-0.36 | -0.20% |
| Sept. 30, 2025 | $-0.33 | $-0.38 | 0.05% |
| June 30, 2025 | $-0.15 | $-0.39 | 0.24% |
| March 31, 2025 | $0.56 | $-0.34 | 0.90% |
| Dec. 31, 2024 | $0.23 | $-0.02 | 0.25% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 12
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $124M | $76M | $0 | |
| R&D Expense | $142M | $122M | $111M | |
| SG&A Expense | $36M | $35M | $32M | |
| Operating Expenses | $178M | $157M | $143M | |
| Operating Income | $-54M | $-81M | $-143M | |
| Other Non-op | $14M | $11M | $8M | |
| Pretax Income | $-40M | $-70M | $-135M | |
| Income Tax | $-1M | $3M | $338.0K | |
| Net Income | $-39M | $-73M | $-135M | |
| Shares (Basic) | 83,071,185 | 73,910,026 | 51,396,961 | |
| Shares (Diluted) | 83,071,185 | 73,910,026 | 51,396,961 | |
| EBITDA | $-54M | $-81M | $-143M |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $130M | $224M | $128M | |
| Prepaid Expense | $4M | $5M | $3M | |
| Current Assets | $393M | $377M | $236M | |
| PP&E (Net) | $26M | $29M | $34M | |
| PP&E (Gross) | $54M | $50M | $46M | |
| Accum. Depreciation | $28M | $20M | $12M | |
| Other Non-current Assets | $148.0K | $115.0K | $352.0K | |
| Total Assets | $449M | $439M | $304M | |
| Accounts Payable | $4M | $17M | $11M | |
| Accrued Liabilities | $27M | $19M | · | |
| Current Liabilities | $64M | $157M | $47M | |
| Capital Leases | $35M | $39M | $43M | |
| Total Liabilities | $216M | $216M | $125M | |
| Common Stock | $7.0K | $6.0K | $5.0K | |
| Retained Earnings | $-477M | $-439M | $-366M | |
| AOCI | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $233M | $223M | $179M | |
| Liabilities + Equity | $449M | $439M | $304M | |
| Shares Outstanding | 65,543,723 | 61,507,446 | 50,140,233 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $19M | $18M | $17M | |
| Amort. of Intangibles | $2M | $2M | $2M | |
| Operating Cash Flow | $-23M | $42M | $-44M | |
| CapEx | $5M | $4M | $19M | |
| Investing Cash Flow | $-102M | $-44M | $89M | |
| Stock Issued | · | · | $0 | |
| Net Stock Activity | · | · | $0 | |
| Dividends Paid | $0 | $0 | $0 | |
| Financing Cash Flow | $30M | $99M | $27M | |
| Net Change in Cash | $-94M | $96M | $72M | |
| Taxes Paid | $5M | $3M | · | |
| Free Cash Flow | $-27M | $38M | $-63M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -43.8% | -107.3% | · | |
| Net Margin | -31.2% | -96.1% | · | |
| Pretax Margin | -32.1% | -92.7% | · | |
| EBITDA Margin | -43.8% | -107.3% | · | |
| ROA | -8.7% | -19.6% | -41.9% | |
| ROE | -15.4% | -33.9% | -74.4% | |
| ROIC | -22.6% | -37.7% | -80.2% |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 6.1 | 2.4 | 5.1 | |
| Quick Ratio | 2.0 | 1.4 | 2.7 |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · |
Growth Rates 1
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 63.5% | · | · |
Valuation (TTM) 11
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $124M | $76M | $0 | |
| Net Income TTM | $-39M | $-73M | $-135M | |
| Market Cap | $1.03B | $427M | $283M | |
| P/S | 8.3 | 5.6 | · | |
| P/B | 4.4 | 1.9 | 1.6 | |
| P / Tangible Book | 4.4 | 1.9 | 1.6 | |
| P / Cash Flow | -45.1 | 10.2 | -6.5 | |
| P / FCF | -37.4 | 11.2 | -4.5 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | |
| Annual Payout | $0 | $0 | $0 |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $13M | $23M | $85M | $61M | $9M | $5M | $1M | $0 | $0 | $0 | $0 | |
| R&D Expense | $44M | $42M | $37M | $31M | $32M | $39M | $28M | $28M | $27M | $27M | $28M | $29M | $27M | |
| SG&A Expense | $10M | $11M | $9M | $8M | $9M | $9M | $8M | $9M | $9M | $8M | $9M | $8M | $8M | |
| Operating Expenses | $54M | $52M | $46M | $39M | $41M | $48M | $36M | $37M | $36M | $35M | $37M | $37M | $34M | |
| Operating Income | $-50M | $-50M | $-33M | $-16M | $44M | $13M | $-27M | $-33M | $-35M | $-35M | $-37M | $-37M | $-34M | |
| Other Non-op | $6M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Pretax Income | $-44M | $-46M | $-30M | $-11M | $48M | $16M | $-24M | $-30M | $-32M | $-33M | $-35M | $-35M | $-32M | |
| Income Tax | $52.0K | $59.0K | $-3M | $1M | $822.0K | $2M | $71.0K | $252.0K | $83.0K | $-22.0K | $170.0K | $190.0K | $0 | |
| Net Income | $-45M | $-46M | $-27M | $-12M | $47M | $13M | $-24M | $-30M | $-32M | $-33M | $-35M | $-35M | $-32M | |
| Shares (Basic) | 99,883,878 | -163,662,055 | 82,397,753 | 82,186,768 | 82,148,719 | -139,491,823 | 82,011,670 | 71,233,992 | 60,156,187 | -97,197,337 | 49,814,903 | 49,431,922 | 49,347,473 | |
| Shares (Diluted) | 99,883,878 | -164,469,759 | 82,397,753 | 82,186,768 | 82,956,423 | -139,491,823 | 82,011,670 | 71,233,992 | 60,156,187 | -97,197,337 | 49,814,903 | 49,431,922 | 49,347,473 | |
| EBITDA | $-50M | · | $-33M | $-16M | $44M | · | $-27M | $-33M | $-35M | · | $-37M | $-37M | $-34M |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $130M | $208M | $69M | $79M | $224M | $126M | $109M | $100M | $128M | $59M | $47M | $52M | |
| Receivables | · | · | · | · | · | · | · | $9M | · | · | · | · | · | |
| Prepaid Expense | $7M | $4M | $6M | $7M | $5M | $5M | $8M | $6M | $6M | $3M | $4M | $4M | $6M | |
| Current Assets | $678M | $393M | $402M | $299M | $332M | $377M | $251M | $278M | $199M | $236M | $183M | $208M | $241M | |
| PP&E (Net) | $28M | $26M | $28M | $29M | $29M | $29M | $31M | $33M | $34M | $34M | $35M | $35M | $33M | |
| PP&E (Gross) | $58M | $54M | $53M | $52M | $51M | $50M | $50M | $49M | $48M | $46M | $45M | $44M | $41M | |
| Accum. Depreciation | $30M | $28M | $26M | $23M | $21M | $20M | $18M | $16M | $14M | $12M | $10M | $9M | $7M | |
| Other Non-current Assets | $832.0K | $148.0K | $411.0K | $445.0K | $440.0K | $115.0K | $159.0K | $209.0K | $389.0K | $352.0K | $270.0K | $291.0K | $351.0K | |
| Total Assets | $736M | $449M | $460M | $360M | $393M | $439M | $315M | $344M | $267M | $304M | $252M | $279M | $309M | |
| Accounts Payable | $8M | $4M | $15M | $6M | $6M | $17M | $4M | $6M | $7M | $11M | $6M | $5M | $7M | |
| Accrued Liabilities | $26M | $27M | · | · | · | $19M | · | · | · | · | · | · | · | |
| Current Liabilities | $71M | $64M | $61M | $42M | $59M | $157M | $42M | $42M | $41M | $47M | $23M | $19M | $21M | |
| Capital Leases | $35M | $35M | $36M | $37M | $38M | $39M | $40M | $41M | $42M | $43M | $44M | $44M | $43M | |
| Total Liabilities | $215M | $216M | $214M | $92M | $118M | $216M | $110M | $119M | $114M | $125M | $68M | $65M | $65M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-522M | $-477M | $-431M | $-404M | $-392M | $-439M | $-452M | $-428M | $-398M | $-366M | $-333M | $-298M | $-263M | |
| AOCI | $-5M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $522M | $233M | $246M | $268M | $275M | $223M | $205M | $225M | $153M | $179M | $185M | $214M | $244M | |
| Liabilities + Equity | $736M | $449M | $460M | $360M | $393M | $439M | $315M | $344M | $267M | $304M | $252M | $279M | $309M | |
| Shares Outstanding | 84,321,705 | 65,543,723 | 61,790,239 | 61,717,349 | 61,509,821 | 61,507,446 | 61,377,484 | 61,328,282 | 50,200,304 | 50,140,233 | 50,065,680 | 49,592,479 | 49,360,984 |
Cash Flow 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Amort. of Intangibles | $643.0K | $648.0K | $637.0K | $615.0K | $574.0K | $511.0K | $578.0K | $211.0K | $800.0K | $100.0K | $500.0K | $700.0K | $800.0K | |
| Operating Cash Flow | $-37M | $-43M | $100M | $-35M | $-45M | $129M | $-21M | $-28M | $-38M | $30M | $-25M | $-25M | $-23M | |
| CapEx | $2M | $767.0K | $651.0K | $2M | $2M | $183.0K | $399.0K | $2M | $1M | $2M | $2M | $7M | $9M | |
| Investing Cash Flow | $-261M | $-65M | $38M | $25M | $-100M | $-31M | $38M | $-61M | $10M | $14M | $36M | $19M | $20M | |
| Stock Issued | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Financing Cash Flow | $328M | $30M | $348.0K | $365.0K | $14.0K | $608.0K | $15.0K | $98M | $246.0K | $25M | $1M | $1M | $18.0K | |
| Net Change in Cash | $30M | $-78M | $139M | $-9M | $-146M | $99M | $17M | $9M | $-28M | $69M | $12M | $-6M | $-3M | |
| Free Cash Flow | $-39M | · | · | · | $-47M | · | · | · | $-40M | · | · | · | $-33M |
Profitability 7
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1188.5% | · | -258.3% | -67.1% | 51.8% | · | -287.8% | -695.2% | -3284.5% | · | · | · | · | |
| Net Margin | -1057.1% | · | -212.1% | -53.0% | 55.2% | · | -258.9% | -645.6% | -3004.5% | · | · | · | · | |
| Pretax Margin | -1055.8% | · | -237.0% | -47.8% | 56.2% | · | -258.1% | -640.2% | -2996.7% | · | · | · | · | |
| EBITDA Margin | -1188.5% | · | -258.3% | -67.1% | 51.8% | · | -287.8% | -695.2% | -3284.5% | · | · | · | · | |
| ROA | -7.9% | · | -7.0% | -3.5% | 14.2% | · | -8.4% | -9.7% | -11.1% | · | -11.4% | -10.9% | -9.8% | |
| ROE | -11.2% | · | -12.0% | -5.0% | 21.9% | · | -12.2% | -13.8% | -16.1% | · | -14.7% | -13.6% | -11.2% | |
| ROIC | -9.6% | · | -12.0% | -6.4% | 15.7% | · | -13.0% | -14.6% | -23.0% | · | -20.1% | -17.5% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | · | 6.5 | 7.2 | 5.6 | · | 6.0 | 6.6 | 4.8 | · | 8.1 | 10.9 | 11.7 | |
| Quick Ratio | 2.3 | · | 3.4 | 1.7 | 1.3 | · | 3.0 | 2.8 | 2.4 | · | 2.6 | 2.5 | 2.5 |
Efficiency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.1 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.0 | · | · | · | · | · |
Valuation (TTM) 9
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $125M | · | $130M | $122M | $100M | · | $15M | $6M | $1M | · | · | · | · | |
| Net Income TTM | $-37M | · | $-16M | $-20M | $-39M | · | $-121M | $-132M | $-134M | · | $-129M | $-121M | $-110M | |
| Market Cap | $1.39B | · | $458M | $278M | $285M | · | $325M | $229M | $354M | · | $240M | $340M | $385M | |
| P/S | 11.1 | · | 3.5 | 2.3 | 2.9 | · | 21.7 | 39.8 | 332.6 | · | · | · | · | |
| P/B | 2.7 | · | 1.9 | 1.0 | 1.0 | · | 1.6 | 1.0 | 2.3 | · | 1.3 | 1.6 | 1.6 | |
| P / Tangible Book | 2.7 | · | 1.9 | 1.0 | 1.0 | · | 1.6 | 1.0 | 2.3 | · | 1.3 | 1.6 | 1.6 | |
| P / Cash Flow | -37.1 | · | · | · | -6.3 | · | · | · | -9.3 | · | · | · | -16.4 | |
| P / FCF | -35.4 | · | · | · | -6.1 | · | · | · | -8.9 | · | · | · | -11.8 | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 0.00% | · | · | · | 0.00% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $124M | $76M | $0 | — | — |
| Operating Margin % | -43.8% | -107.3% | — | — | — |
| Net Income | $-39M | $-73M | $-135M | $-109M | $-74M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 6.1 | 2.4 | 5.1 | 10.8 | 21.0 |
| Quick Ratio | 2.0 | 1.4 | 2.7 | 2.1 | 20.8 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-27M | $38M | $-63M | $-105M | $-69M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.